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YEAR IN CARDIOLOGY SERIES YEAR IN CARDIOLOGY SERIES1425The Year in Cardiovascular SurgeryDavid H. Adams, Joanna Chikwe, Farzan Filsoufi, Anelechi C. Anyanwu
The 2009 literature in cardiovascular surgery produced several pivotal reports that will affect
patient care and future trial design for years to come. Adams and colleagues highlight key
papers that focus on strategies and outcomes in cardiovascular surgery with a particular
emphasis on papers that compare surgical to nonsurgical treatment strategies or those that
emphasize potential advances in specific surgical strategies. The goal is to provide readers with
a succinct summary of specific studies with pointed comments to highlight special significance
or methodological limitations.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
1445Stent Thrombosis and Bleeding Complications
After Implantation of Sirolimus-Eluting Coronary StentPhilip Urban, Alexandre Abizaid, Adrian Banning, Antonio L. Bartorelli, Ana Cebrian Baux,
Vladimı´r Džavı´k, Stephen Ellis, Runlin Gao, David Holmes, Myung Ho Jeong, Victor Legrand,
Franz-Josef Neumann, Maria Nyakern, Christian Spaulding, Stephen Worthley,
for the e-SELECT Investigators
Urban and colleagues used a multinational registry of unselected patients to ascertain the
1-year incidence of stent thrombosis (ST) and major bleeding (MB) in patients treated with
sirolimus-eluting stents. In over 15,000 subjects the incidence of definite and probable ST
was 1.0%, and there was also a 1.0% incidence of MB. Multivariate analysis showed that
discontinuing dual antiplatelet therapy during the first 30 days produced a significantly
increased risk of ST (hazard ratio: 2.2), while a low baseline hemoglobin and a high Charlson
index increased the risk of both ST and MB. Following ST, the 7-day mortality was 30%
compared with only 1.5% after MB.(continued on page A-22)
MARCH 29, 2011 (continued) A-22CORONARY ARTERY DISEASE1455CRP and CAC Provide Complementary Prognostic InformationStefan Möhlenkamp, Nils Lehmann, Susanne Moebus, Axel Schmermund, Nico Dragano,
Andreas Stang, Johannes Siegrist, Klaus Mann, Karl-Heinz Jöckel, Raimund Erbel,
on behalf of the Heinz Nixdorf Recall Study Investigators
Möhlenkamp and colleagues assessed Framingham risk variables, high-sensitivity C-reactive
protein (hsCRP), and coronary artery calcium (CAC) in almost 4,000 subjects without
known coronary artery disease or acute inflammation. During 5 years of follow-up, CAC
and hsCRP independently predicted coronary events and deaths. Net reclassification
improved by 24% for CAC and by 10% for hsCRP. The improvement in risk prediction
and discrimination was predominantly driven by CAC, whereas hsCRP appears to be
particularly useful in persons with low CAC scores.Editorial Comment: Christian W. Hamm, Holger M. Nef, Andreas Rolf, Helge Möllmann, p. 1465HEART FAILURE
1468LV Reverse Remodeling With Medical Therapy
Is Associated With Improved OutcomesMarco Merlo, Stylianos A. Pyxaras, Bruno Pinamonti, Giulia Barbati, Andrea Di Lenarda,
Gianfranco Sinagra
Merlo and colleagues studied the prevalence and prognostic significance of left ventricular
reverse remodeling (LVRR) in patients with idiopathic dilated cardiomyopathy (IDCM)
treated with medical therapy. LVRR was defined as an increase in left ventricular (LV)
ejection fraction and a reduction of indexed LV end-diastolic diameter at 24 months.
LVRR occurred in one-third of patients. Those with LVRR were significantly less likely
to die or undergo heart transplantation (HTx) during continued follow-up. LVRR occurs
in approximately one-third of IDCM patients treated with optimal medical therapy who
survive 2 years, and it identifies patients at lower risk of subsequent serious outcomes.
Editorial Comment: James E. Udelson, Marvin A. Konstam, p. 1477(continued on page A-24)
MARCH 29, 2011 (continued) A-24VASCULAR DISEASE1480Arterial Calcification Predicts Arterial StiffeningMarina Cecelja, Benyu Jiang, Lisa Bevan, Michelle L. Frost, Tim D. Spector, Phil J. Chowienczyk
Cecelja and colleagues examined the relationship among carotid-femoral pulse wave velocity
(cfPWV), carotid intima-media thickening (IMT), carotid/femoral plaque, aortic calcification,
and bone mineral density (BMD), and the heritability of these measures. In 900 women from
the Twins-UK cohort, cfPWV was independently correlated with calcified plaque but not
IMT or noncalcified plaque. There was no independent association between cfPWV and
BMD. Shared genetic factors accounted for 92% of the observed correlation between cfPWV
and calcified plaque. These results suggest that the association between increased arterial
stiffness and arterial wall calcification is explained by a common genetic etiology.CONGENITAL HEART DISEASE
1487Fetal AV Prolongation Does Not Predict Progressive Heart Block
in Fetuses Exposed to Maternal AntibodiesEdgar T. Jaeggi, Earl D. Silverman, Carl Laskin, John Kingdom, Fraser Golding, Roland Weber
Some have postulated that antibody-mediated congenital complete atrioventricular block
(CAVB) may be preventable if detected and treated early with dexamethasone when low-
grade block is present. Jaeggi and colleagues prospectively examined the natural history of
fetal atrioventricular (AV) prolongation in the presence of maternal anti-Ro antibodies in
165 fetuses. Subjects had weekly evaluation of the fetal AV conduction. Of 150 cases with
persistently normal AV conduction, 1 subsequently developed CAVB at 28 weeks. Of 15
fetuses with AV prolongation or type 1 second-degree block, none developed progressive
heart block. Fetal AV prolongation does not predict progressive heart block, and these
findings question the utility of early identification and treatment of fetal AV prolongation.
